Search Results - "Gynecologic oncology research and practice"

Extra-uterine low grade endometrioid stromal sarcoma arising from ovarian endometriosis: a case report and review of the literature by Efared, Boubacar, Sidibé, Ibrahim S, Erregad, Fatimazahra, Hammas, Nawal, Chbani, Laila, El Fatemi, Hinde

“…Endometrial stromal sarcoma (ESS) is a rare neoplasm accounting for only 0.2% of female genital tract tumors. The primary extra-uterine location of ESS is an…”
Get full text

Preferences of women with epithelial ovarian cancer for aspects of genetic testing by Davidson, Brittany A, Ehrisman, Jessie, Reed, Shelby D, Yang, Jui-Chen, Buchanan, Adam, Havrilesky, Laura J

“…Although genetic testing is recommended for women with epithelial ovarian cancer (EOC), little is known about patient preferences for various testing options…”
Get full text

Safety and feasibility of contained uterine morcellation in women undergoing laparoscopic hysterectomy by Dotson, Sarah, Landa, Alejandro, Ehrisman, Jessie, Secord, Angeles Alvarez

“…Widespread concerns have been raised regarding the safety of power morcellation of uterine specimens because of the potential to disseminate occult malignancy…”
Get full text

A small molecule inhibitor of the perinucleolar compartment, ML246, attenuates growth and spread of ovarian cancer by Kanis, Margaux J, Qiang, Wenan, Pineda, Mario, Maniar, Kruti P, Kim, J Julie

“…Ovarian cancer remains a major health problem for women as it is often diagnosed at a late stage with metastatic disease. There are limited therapeutic agents…”
Get full text

Response to pembrolizumab in a heavily treated patient with metastatic ovarian carcinosarcoma by Zibetti Dal Molin, Graziela, Abrahão, Carina Meira, Coleman, Robert L, Maluf, Fernando Cotait

“…Ovarian carcinosarcoma is a rare malignancy associated with a high rate of cancer-related mortality even at early stages. Guidelines for systemic treatment…”
Get full text

Meeting report, “First Indian national conference on cervical cancer management - expert recommendations and identification of barriers to implementation” by Tewari, K. S, Agarwal, A, Pathak, A, Ramesh, A, Parikh, B, Singhal, M, Saini, G, Sushma, P. V, Huilgol, N, Gundeti, S, Gupta, S, Nangia, S, Rawat, S, Alurkar, S, Goswami, V, Swarup, B, Ugile, B, Jain, S, Kukreja, A

“…Objective In India, cervical cancer accounts for almost 14% of all female cancer cases. Although poverty continues to cast a wide net over the Indian…”
Get full text

The utility of patient reported data in a gynecologic oncology clinic by Barnes, D, Rivera, R, Gibson, S, Craig, C, Cragun, J, Monk, B, Chase, D

“…Measuring QoL is essential to the field of gynecologic oncology but there seems to be limited standardized data regarding collecting QoL assessments throughout…”
Get full text

Socio-demographic characteristics influencing cervical cancer screening intention of HIV-positive women in the central region of Ghana by Ebu, Nancy Innocentia

“…The burden of HIV and cervical cancer is concentrated in sub-Saharan Africa. Women with HIV are more likely to have persistent HPV infection leading to…”
Get full text

Improving attendance to genetic counselling services for gynaecological oncology patients by Pokharel, Hanoon P, Hacker, Neville F, Andrews, Lesley

“…Gynaecological cancers may be the sentinel malignancy in women who carry a mutation in BRCA1 or 2, a mis-match repair gene causing Lynch Syndrome or other…”
Get full text

Clinical trial experience with CA4P anticancer therapy: focus on efficacy, cardiovascular adverse events, and hypertension management by Grisham, Rachel, Ky, Bonnie, Tewari, Krishnansu S, Chaplin, David J, Walker, Joan

“…Combretastatin A4-phosphate (CA4P) is a vascular-disrupting agent (VDA) in clinical development for the treatment of ovarian and other cancers. In contrast to…”
Get full text

Comprehensive knowledge and uptake of cervical cancer screening is low among women living with HIV/AIDS in Northwest Ethiopia by Erku, Daniel Asfaw, Netere, Adeladlew Kassie, Mersha, Amanual Getnet, Abebe, Sileshi Ayele, Mekuria, Abebe Basazn, Belachew, Sewunet Admasu

“…In Ethiopia, cervical cancer is ranked as the second most common type of cancer in women and it is about 8 times more common in HIV infected women. However,…”
Get full text

New therapies for advanced, recurrent, and metastatic endometrial cancers by Makker, Vicky, Green, Angela K, Wenham, Robert M, Mutch, David, Davidson, Brittany, Miller, David Scott

“…Endometrial cancer is the most common gynecologic malignancy in the United States, accounting for 6% of cancers in women. In 2017, an estimated 61,380 women…”
Get full text

PARP inhibitors as potential therapeutic agents for various cancers: focus on niraparib and its first global approval for maintenance therapy of gynecologic cancers by Sisay, Mekonnen, Edessa, Dumessa

“…Poly (ADP-ribose) polymerases (PARPs) are an important family of nucleoproteins highly implicated in DNA damage repair. Among the PARP families, the most…”
Get full text

A retrospective evaluation of activity of gemcitabine/platinum regimens in the treatment of recurrent ovarian cancer by Le, Tran N, Harvey, Rachel E, Kim, Christine K, Brown, Jubilee, Coleman, Robert L, Smith, Judith A

“…While many of these agents have been compared in prospective clinical trials, the gemcitabine/platinumbased regimens have not been compared in a prospective,…”
Get full text

EZH2 inhibition in ARID1A mutated clear cell and endometrioid ovarian and endometrioid endometrial cancers by Alldredge, Jill K, Eskander, Ramez N

“…Clear cell carcinoma and endometrioid adenocarcinoma are histologic subtypes of ovarian and uterine cancer that demonstrate unique clinical behavior but share…”
Get full text

Assessment of drug therapy problems among patients with cervical cancer at Kenyatta National Hospital, Kenya by Degu, Amsalu, Njogu, Peter, Weru, Irene, Karimi, Peter

“…Although cervical cancer is preventable, it is still the second leading cause of cancer deaths among women in the world. Further, it is estimated that around…”
Get full text

Preparation in the business and practice of medicine: perspectives from recent gynecologic oncology graduates and program directors by Schlumbrecht, Matthew, Siemon, John, Morales, Guillermo, Huang, Marilyn, Slomovitz, Brian

“…Preparation in the business of medicine is reported to be poor across a number of specialties. No data exist about such preparation in gynecologic oncology…”
Get full text

Bringing new medicines to women with epithelial ovarian cancer: what is the unmet medical need? by Herzog, Thomas J, Monk, Bradley J

“…Therapy for advanced epithelial ovarian cancer (OC) includes first line platinum/taxane-containing chemotherapy and re-treatment with platinum-containing…”
Get full text

Transversus abdominis plane block with liposomal bupivacaine compared to oral opioids alone for acute postoperative pain after laparoscopic hysterectomy for early endometrial cancer: a cost-effectiveness analysis by Seagle, Brandon-Luke L, Miller, Emily S, Strohl, Anna E, Hoekstra, Anna, Shahabi, Shohreh

“…To determine the cost-effectiveness of transversus abdominis plane block with liposomal bupivacaine (TAP) compared to oral opioids alone for acute…”
Get full text

Multidisciplinary approach to manage antenatally suspected placenta percreta: updated algorithm and patient outcomes by Lee, Paula S, Kempner, Samantha, Miller, Michael, Dominguez, Jennifer, Grotegut, Chad, Ehrisman, Jessie, Previs, Rebecca, Havrilesky, Laura J, Broadwater, Gloria, Ellestad, Sarah C, Secord, Angeles Alvarez

“…Due to the significant morbidity and mortality associated with placenta percreta, alternative management options are needed. Beginning in 2005, our institution…”
Get full text